Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Donor serum SMARCAL1 concentrations predict primary graft dysfunction in cardiac transplantation.

Aharinejad S, Andrukhova O, Gmeiner M, Thomas A, Aliabadi A, Zuckermann A, Krenn K, Grimm M.

Circulation. 2009 Sep 15;120(11 Suppl):S198-205. doi: 10.1161/CIRCULATIONAHA.108.842971.

2.

Concomitant endothelin-1 overexpression in lung transplant donors and recipients predicts primary graft dysfunction.

Salama M, Andrukhova O, Hoda MA, Taghavi S, Jaksch P, Heinze G, Klepetko W, Aharinejad S.

Am J Transplant. 2010 Mar;10(3):628-36. doi: 10.1111/j.1600-6143.2009.02957.x. Epub 2010 Jan 5.

3.

Donor myocardial apollon mRNA is associated with cardiac allograft rejection.

Aharinejad S, Andrukhova O, Gmeiner M, Thomas A, Aliabadi A, Zuckermann A, Grimm M.

J Heart Lung Transplant. 2010 Jul;29(7):777-85. doi: 10.1016/j.healun.2010.03.011. Epub 2010 May 11.

PMID:
20462770
4.

Donor myocardial HIF-1alpha is an independent predictor of cardiac allograft dysfunction: a 7-year prospective, exploratory study.

Aharinejad S, Schäfer R, Krenn K, Zuckermann A, Schneider B, Neumann F, Paulus P, Wieselthaler G, Wolner E, Grimm M.

Am J Transplant. 2007 Aug;7(8):2012-9.

5.

Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation.

Lima B, Rajagopal K, Petersen RP, Shah AS, Soule B, Felker GM, Rogers JG, Lodge AJ, Milano CA.

Circulation. 2006 Jul 4;114(1 Suppl):I27-32.

6.

Recipient vascular endothelial growth factor serum levels predict primary lung graft dysfunction.

Krenn K, Klepetko W, Taghavi S, Lang G, Schneider B, Aharinejad S.

Am J Transplant. 2007 Mar;7(3):700-6. Epub 2007 Jan 22.

7.

Donor cardiac troponin I levels do not predict recipient survival after cardiac transplantation.

Khush KK, Menza RL, Babcock WD, Zaroff JG.

J Heart Lung Transplant. 2007 Oct;26(10):1048-53.

PMID:
17919626
8.

Biomarkers of cellular apoptosis and necrosis in donor myocardium are not predictive of primary graft dysfunction.

Szarszoi O, Besik J, Smetana M, Maly J, Urban M, Maluskova J, Lodererova A, Hoskova L, Tucanova Z, Pirk J, Netuka I.

Physiol Res. 2016 Jun 20;65(2):251-7. Epub 2015 Oct 8.

9.

The implications of pulmonary embolism in a multiorgan donor for subsequent pulmonary, renal, and cardiac transplantation.

Oto T, Excell L, Griffiths AP, Levvey BJ, Snell GI.

J Heart Lung Transplant. 2008 Jan;27(1):78-85. doi: 10.1016/j.healun.2007.10.001.

PMID:
18187091
10.

Association between primary graft dysfunction among lung, kidney and heart recipients from the same multiorgan donor.

Oto T, Excell L, Griffiths AP, Levvey BJ, Bailey M, Marasco S, Macdonald P, Snell GI.

Am J Transplant. 2008 Oct;8(10):2132-9. doi: 10.1111/j.1600-6143.2008.02357.x. Epub 2008 Aug 22.

11.

Donor pharmacological hemodynamic support is associated with primary graft failure in human heart transplantation.

Santise G, D'Ancona G, Falletta C, Pirone F, Sciacca S, Turrisi M, Biondo D, Pilato M.

Interact Cardiovasc Thorac Surg. 2009 Sep;9(3):476-9. doi: 10.1510/icvts.2009.202085. Epub 2009 Jun 29.

PMID:
19564203
12.

Serum troponin Ic values in organ donors are related to donor myocardial dysfunction but not to graft dysfunction or rejection in the recipients.

Boccheciampe N, Audibert G, Rangeard O, Charpentier C, Perrier JF, Lalot JM, Voltz C, Strub P, Loos-Ayav C, Meistelman C, Mertes PM, Longrois D.

Int J Cardiol. 2009 Mar 20;133(1):80-6. doi: 10.1016/j.ijcard.2007.12.006. Epub 2008 Feb 5.

PMID:
18255177
13.

Prognostic Value of High-Sensitivity Troponin-T to Identify Patients at Risk of Left Ventricular Graft Dysfunction After Heart Transplantation.

Méndez AB, Ordonez-Llanos J, Mirabet S, Galan J, Maestre ML, Brossa V, Rivilla MT, López L, Koller T, Sionis A, Roig E.

Transplant Proc. 2016 Nov;48(9):3021-3023. doi: 10.1016/j.transproceed.2016.07.044.

PMID:
27932136
14.

Impact of human donor lung gene expression profiles on survival after lung transplantation: a case-control study.

Anraku M, Cameron MJ, Waddell TK, Liu M, Arenovich T, Sato M, Cypel M, Pierre AF, de Perrot M, Kelvin DJ, Keshavjee S.

Am J Transplant. 2008 Oct;8(10):2140-8. doi: 10.1111/j.1600-6143.2008.02354.x. Epub 2008 Aug 22.

15.

Report from a consensus conference on primary graft dysfunction after cardiac transplantation.

Kobashigawa J, Zuckermann A, Macdonald P, Leprince P, Esmailian F, Luu M, Mancini D, Patel J, Razi R, Reichenspurner H, Russell S, Segovia J, Smedira N, Stehlik J, Wagner F; Consensus Conference participants.

J Heart Lung Transplant. 2014 Apr;33(4):327-40. doi: 10.1016/j.healun.2014.02.027. Epub 2014 Mar 5.

PMID:
24661451
16.

Twinned single-lung transplantation: a privileged model for the study of recipient-dependent factors of outcome.

Olland A, Santelmo N, Orsini B, Falcoz PE, Dorent R, Mal H, Thomas P, Massard G.

Eur J Cardiothorac Surg. 2012 Jun;41(6):1357-64; discussion 1364-5. doi: 10.1093/ejcts/ezr234. Epub 2012 Jan 12.

PMID:
22241010
17.

[Interleukin 8 concentrations in donor bronchoalveolar lavage: impact on primary graft failure in double lung transplant].

Almenar M, Cerón J, Gómez MA, Peñalver JC, Jiménez MA, Padilla J.

Arch Bronconeumol. 2009 Jan;45(1):12-5. doi: 10.1016/j.arbres.2008.02.004. Epub 2009 Jan 3. Spanish.

18.

Effect of adenosine monophosphate deaminase-1 C34T allele on the requirement for donor inotropic support and on the incidence of early graft dysfunction after cardiac transplantation.

Taegtmeyer AB, Breen JB, Rogers P, Johnson PH, Smith J, Smolenski RT, Banner NR, Yacoub MH, Barton PJ.

Am J Cardiol. 2009 May 15;103(10):1457-62. doi: 10.1016/j.amjcard.2009.01.360. Epub 2009 Apr 1.

PMID:
19427446
19.

A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.

Khan TA, Schnickel G, Ross D, Bastani S, Laks H, Esmailian F, Marelli D, Beygui R, Shemin R, Watson L, Vartapetian I, Ardehali A.

J Thorac Cardiovasc Surg. 2009 Dec;138(6):1417-24. doi: 10.1016/j.jtcvs.2009.04.063.

20.

Serum matrix metalloprotease-1 and vascular endothelial growth factor--a predict cardiac allograft rejection.

Aharinejad S, Krenn K, Zuckermann A, Schäfer R, Gmeiner M, Thomas A, Aliabadi A, Schneider B, Grimm M.

Am J Transplant. 2009 Jan;9(1):149-59. doi: 10.1111/j.1600-6143.2008.02470.x. Epub 2008 Nov 27.

Supplemental Content

Support Center